These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25822686)

  • 41. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells.
    Lloyd JM; McIver CM; Stephenson SA; Hewett PJ; Rieger N; Hardingham JE
    Clin Cancer Res; 2006 Jan; 12(2):417-23. PubMed ID: 16428481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between post-surgery detection of methylated circulating tumor DNA with risk of residual disease and recurrence-free survival.
    Murray DH; Symonds EL; Young GP; Byrne S; Rabbitt P; Roy A; Cornthwaite K; Karapetis CS; Pedersen SK
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1741-1750. PubMed ID: 29992492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer.
    Gharib E; Nasrinasrabadi P; Zali MR
    PLoS One; 2020; 15(3):e0229864. PubMed ID: 32155177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer.
    Cleven AH; Derks S; Draht MX; Smits KM; Melotte V; Van Neste L; Tournier B; Jooste V; Chapusot C; Weijenberg MP; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2014 Jun; 20(12):3261-71. PubMed ID: 24928946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A molecular signature for the prediction of recurrence in colorectal cancer.
    Wang L; Shen X; Wang Z; Xiao X; Wei P; Wang Q; Ren F; Wang Y; Liu Z; Sheng W; Huang W; Zhou X; Du X
    Mol Cancer; 2015 Feb; 14(1):22. PubMed ID: 25645394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic role of methylated free circulating DNA in colorectal cancer.
    Philipp AB; Stieber P; Nagel D; Neumann J; Spelsberg F; Jung A; Lamerz R; Herbst A; Kolligs FT
    Int J Cancer; 2012 Nov; 131(10):2308-19. PubMed ID: 22362391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
    Lin YL; Wang YL; Ma JG; Li WP
    J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypomethylation-associated up-regulation of TCF3 expression and recurrence in stage II and III colorectal cancer.
    Li C; Cai S; Wang X; Jiang Z
    PLoS One; 2014; 9(11):e112005. PubMed ID: 25375219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
    Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
    Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Value of Molecular Detection of Lymph Node Metastases After Curative Resection of Stage II Colon Cancer: A Systematic Pooled Data Analysis.
    Gill S; Haince JF; Shi Q; Pavey ES; Beaudry G; Sargent DJ; Fradet Y
    Clin Colorectal Cancer; 2015 Jun; 14(2):99-105. PubMed ID: 25619805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcome of salvage surgery for colorectal cancer initially treated by upfront endoscopic therapy.
    Nozawa H; Ishihara S; Fujishiro M; Kodashima S; Ohtani K; Yasuda K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Kazama S; Sunami E; Kitayama J; Watanabe T
    Surgery; 2016 Mar; 159(3):713-20. PubMed ID: 26477474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A large-scale multicenter study of long-term outcomes after endoscopic resection for submucosal invasive colorectal cancer.
    Yoda Y; Ikematsu H; Matsuda T; Yamaguchi Y; Hotta K; Kobayashi N; Fujii T; Oono Y; Sakamoto T; Nakajima T; Takao M; Shinohara T; Fujimori T; Kaneko K; Saito Y
    Endoscopy; 2013 Sep; 45(9):718-24. PubMed ID: 23918621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.
    Ahmed S; Fields A; Pahwa P; Chandra-Kanthan S; Zaidi A; Le D; Haider K; Reeder B; Leis A
    Clin Colorectal Cancer; 2015 Dec; 14(4):e41-7. PubMed ID: 26140732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant?
    Peeples C; Shellnut J; Wasvary H; Riggs T; Sacksner J
    Dis Colon Rectum; 2010 Nov; 53(11):1517-23. PubMed ID: 20940600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
    Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
    Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
    Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
    World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
    Renehan AG; Jones J; Potten CS; Shalet SM; O'Dwyer ST
    Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA methylation markers and early recurrence in stage I lung cancer.
    Brock MV; Hooker CM; Ota-Machida E; Han Y; Guo M; Ames S; Glöckner S; Piantadosi S; Gabrielson E; Pridham G; Pelosky K; Belinsky SA; Yang SC; Baylin SB; Herman JG
    N Engl J Med; 2008 Mar; 358(11):1118-28. PubMed ID: 18337602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CpG island hypermethylation of E-cadherin (CDH1) and integrin alpha4 is associated with recurrence of early stage esophageal squamous cell carcinoma.
    Lee EJ; Lee BB; Han J; Cho EY; Shim YM; Park J; Kim DH
    Int J Cancer; 2008 Nov; 123(9):2073-9. PubMed ID: 18697202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene pair based prognostic signature for colorectal colon cancer.
    Shu P; Wu J; Tong Y; Xu C; Zhang X
    Medicine (Baltimore); 2018 Oct; 97(42):e12788. PubMed ID: 30334969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.